4//SEC Filing
Evanson Jeff 4
Accession 0001209191-22-022674
CIK 0001649989other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:47 PM ET
Size
6.1 KB
Accession
0001209191-22-022674
Insider Transaction Report
Form 4
Evanson Jeff
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-31+100,000→ 100,000 totalExercise: $1.44Exp: 2031-12-21→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares that vested under a performance-based stock option grant based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting conditions of the option, such shares were not reportable under Section 16 until vesting was determined, which occurred on March 31, 2022. The vested shares represents the first of three possible vesting events of the total number of shares subject to the option. The remaining shares subject to the option will vest only upon the satisfaction of additional performance vesting criteria.
- [F2]Fully vested and immediately exercisable.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001760511
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 6:47 PM ET
- Size
- 6.1 KB